Glycosaminoglycan in malignant pleural mesothelioma
- 1 January 1986
- Vol. 57 (1) , 106-110
- https://doi.org/10.1002/1097-0142(19860101)57:1<106::aid-cncr2820570122>3.0.co;2-c
Abstract
The quantitative analysis on glycosaminoglycan (GAG) in the tumor tissues of five patients with malignant pleural mesothelioma and in the pleural fluid of two patients was performed with the use of biochemical methods. In the tumor tissues, it was found that the average of the total amount of GAG was more than 7.9 times as high as that in adenocarcinoma of the lung, and that hyaluronic acid and chondroitin sulfate were main constituents of mesothelioma GAG. However, there was no significant difference in the content of dermatan sulfate and heparan sulfate between this neoplasm and adenocarcinoma. In the pleural fluid, the amount of hyaluronic acid was about 40 to 230 times higher than that in adenocarcinoma of the lung with the increment of chondroitin sulfate (11–87 times). These findings suggest that a marked increase in the total amount of GAG and the elevation of either the hyaluronic acid or the chondroitin sulfate level, or both, are characteristic abnormalities in malignant pleural mesothelioma.This publication has 6 references indexed in Scilit:
- Analysis of hyaluronic acid in the diagnosis of malignant mesotheliomaCancer, 1984
- Glycosaminoglycans of pleural mesothelioma: A possible biochemical variant containing chondroitin sulfateCancer, 1981
- Electrophoresis of tissue glycosaminoglycans as an aid in the diagnosis of mesotheliomasCancer, 1979
- Malignant mesothelioma. Current status and future prospects.Chest, 1978
- Acid glycosaminoglycans (mucopolysaccharides) in the differential diagnosis of pleural effusionClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- A Method for the Separation of Acid Mucopolysaccharides: Its Application to the Isolation of Heparin from the Skin of RatsJournal of Biological Chemistry, 1961